<VariationArchive RecordType="classified" VariationID="689744" VariationName="NM_000489.6(ATRX):c.477del (p.Lys159fs)" VariationType="Deletion" Accession="VCV000689744" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-09-21" MostRecentSubmission="2019-09-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="677477" VariationID="689744">
      <GeneList>
        <Gene Symbol="ATRX" FullName="ATRX chromatin remodeler" GeneID="546" HGNC_ID="HGNC:886" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="77504880" stop="77786216" display_start="77504880" display_stop="77786216" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="76760355" stop="77041718" display_start="76760355" display_stop="77041718" Strand="-" />
          </Location>
          <OMIM>300032</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000489.6(ATRX):c.477del (p.Lys159fs)</Name>
      <CanonicalSPDI>NC_000023.11:77693830:TTTTTT:TTTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="77693831" stop="77693831" display_start="77693831" display_stop="77693831" variantLength="1" positionVCF="77693830" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="76949320" stop="76949320" display_start="76949320" display_stop="76949320" variantLength="1" positionVCF="76949319" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K159fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1153" sequenceAccession="LRG_1153">
            <Expression>LRG_1153:g.97439del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.76949325del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.76949325del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.77693836del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.77693836del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008838.3" sequenceAccession="NG_008838" sequenceVersion="3" change="g.97439del">
            <Expression>NG_008838.3:g.97439del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000489.6" sequenceAccession="NM_000489" sequenceVersion="6" change="c.477del" MANESelect="true">
            <Expression>NM_000489.6:c.477del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000480.3" sequenceAccession="NP_000480" sequenceVersion="3" change="p.Lys159fs">
            <Expression>NP_000480.3:p.Lys159fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_138270.5" sequenceAccession="NM_138270" sequenceVersion="5" change="c.370+2746del">
            <Expression>NM_138270.5:c.370+2746del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1603240572" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000489.6(ATRX):c.477del (p.Lys159fs) AND multiple conditions" Accession="RCV000850532" Version="1">
        <ClassifiedConditionList TraitSetID="12519">
          <ClassifiedCondition DB="MedGen" ID="C1845055">Alpha thalassemia-X-linked intellectual disability syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4759781">Intellectual disability-hypotonic facies syndrome, X-linked, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-12-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-09-21" MostRecentSubmission="2019-09-21">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="12519" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="281" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ALPHA-THALASSEMIA/IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Alpha thalassemia-X-linked intellectual disability syndrome</ElementValue>
                <XRef ID="MONDO:0010519" DB="MONDO" />
                <XRef ID="715342005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATR-X syndrome</ElementValue>
                <XRef ID="ATR-X+Syndrome/647" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha thalassemia mental retardation syndrome, nondeletion type, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATR, nondeletion type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">XLMR hypotonic face syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha-Thalassemia X-Linked Intellectual Disability  Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked alpha-thalassemia-mental retardation syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300032.0010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATRX</ElementValue>
                <XRef Type="MIM" ID="301040" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5864" />
                <XRef ID="5864" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.</Attribute>
                <XRef ID="NBK1449" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301622</ID>
                <ID Source="BookShelf">NBK1449</ID>
              </Citation>
              <XRef ID="847" DB="Orphanet" />
              <XRef ID="C1845055" DB="MedGen" />
              <XRef ID="MONDO:0010519" DB="MONDO" />
              <XRef Type="MIM" ID="301040" DB="OMIM" />
            </Trait>
            <Trait ID="5503" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HOLMES-GANG SYNDROME</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XLMR-HYPOTONIC FACIES SYNDROME</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation-hypotonic facies syndrome X-linked, 1</ElementValue>
                <XRef ID="Mental+retardation-hypotonic+facies+syndrome+X-linked%2C+1/4666" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Smith Fineman Myers syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHUDLEY-LOWRY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chudley syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chudley-Lowry-Hoar syndrome</ElementValue>
                <XRef ID="MONDO:0019775" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carpenter-Waziri syndrome</ElementValue>
                <XRef ID="MONDO:0019777" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability-hypotonic facies syndrome, X-linked, 1</ElementValue>
                <XRef ID="MONDO:0010663" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked intellectual disability-hypotonic face syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRXHF1</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.</Attribute>
                <XRef ID="NBK1449" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301622</ID>
                <ID Source="BookShelf">NBK1449</ID>
              </Citation>
              <XRef ID="73220" DB="Orphanet" />
              <XRef ID="93970" DB="Orphanet" />
              <XRef ID="93971" DB="Orphanet" />
              <XRef ID="93972" DB="Orphanet" />
              <XRef ID="93973" DB="Orphanet" />
              <XRef ID="93974" DB="Orphanet" />
              <XRef ID="93975" DB="Orphanet" />
              <XRef ID="C4759781" DB="MedGen" />
              <XRef ID="MONDO:0010663" DB="MONDO" />
              <XRef Type="MIM" ID="309580" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1946383" SubmissionDate="2019-03-14" DateLastUpdated="2019-09-21" DateCreated="2019-09-21">
        <ClinVarSubmissionID localKey="NC_000023.10:g.76949325delT|OMIM:301040;309580" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000992741" DateUpdated="2019-09-21" DateCreated="2019-09-21" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATRX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.76949325delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="301040" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="309580" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5321481</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1946383" TraitType="Disease" MappingType="XRef" MappingValue="301040" MappingRef="OMIM">
        <MedGen CUI="C1845055" Name="Alpha thalassemia-X-linked intellectual disability syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1946383" TraitType="Disease" MappingType="XRef" MappingValue="309580" MappingRef="OMIM">
        <MedGen CUI="C4759781" Name="Intellectual disability-hypotonic facies syndrome, X-linked, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

